Differentially expressed genes in peripheral T cells obtained from patients with relapsing-remitting multiple sclerosis after treatment with intravenous immunoglobulins

被引：0
|
作者：
Pigard, N
Kuusisto, H
Paalavuo, R
Elovaara, I
Schwarz, HP
Reipert, B
机构：
[1] BMT Res, Vienna, Austria
[2] Tampere Univ Hosp, Tampere, Finland
[3] Baxter Biosci, Vienna, Austria
来源：
MULTIPLE SCLEROSIS | 2005年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S113 / S113
页数：1
相关论文
共 50 条
  • [1] Gene expression profiles of peripheral T-cells in patients with relapsing-remitting multiple sclerosis after treatment with intravenous immunoglobulins
    Pigard, N.
    Kuusisto, H.
    Elovaara, I.
    Paalavuo, R.
    Zimmermann, K.
    Schwarz, H. P.
    Reipert, B.
    EUROPEAN JOURNAL OF NEUROLOGY, 2004, 11 : 293 - 293
  • [2] Effects of intravenous immunoglobulins treatment of patients with relapsing-remitting multiple sclerosis on gene expression profiles of their peripheral T-cells
    Pigard, N.
    Kuusisto, H.
    Elovaara, I.
    Paalavuo, R.
    Schwarz, H. P.
    Reipert, B.
    EUROPEAN JOURNAL OF NEUROLOGY, 2005, 12 : 273 - 273
  • [3] Mechanisms of action of intravenous immunoglobulins in patients with relapsing-remitting multiple sclerosis
    Pigard, N
    Kuusisto, H
    Elovaara, L
    Paalavuo, R
    Zimmermann, K
    Schwarz, HR
    Reipert, B
    JOURNAL OF NEUROLOGY, 2004, 251 : 185 - 185
  • [4] Intravenous immunoglobulins for relapsing-remitting multiple sclerosis after failure of treatment with other immuno-modulators.
    Lebrun, C
    Ghetau, G
    Bourg, V
    Chanalet, S
    Dumas, S
    Chatel, M
    REVUE NEUROLOGIQUE, 2003, 159 (6-7) : 648 - 651
  • [5] IVIG treatment of patients with relapsing-remitting multiple sclerosis induces a number of differentially expressed genes in peripheral T cells that are involved in the regulation of immune- and inflammatory responses, signal transduction and cell cycle
    Pigard, N
    Kuusisto, HM
    Elovaara, I
    Reipert, B
    Schwarz, HP
    NEUROLOGY, 2006, 66 (05) : A372 - A372
  • [6] How effective is intravenous immunoglobulin for the treatment of relapsing-remitting multiple sclerosis?
    Cohen, Jeffrey A.
    NATURE CLINICAL PRACTICE NEUROLOGY, 2008, 4 (11): : 588 - 589
  • [7] Influence of Alemtuzumab Treatment on Peripheral Mediators of Inflammation in Relapsing-Remitting Multiple Sclerosis Patients
    Studer, Valeria
    Ferri, Anna
    Perugini, Jacopo
    Clerici, Valentina Torri
    Confalonieri, Paolo
    Antozzi, Carlo
    Mantegazza, Renato
    Schilke, Edoardo
    Brambilla, Laura
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 25 - 26
  • [8] IVIG treatment in patients with relapsing-remitting multiple sclerosis: New insights into gene expression profiles of peripheral T-cells
    Pigard, N.
    Kuusisto, H.
    Elovaara, I.
    Raija, P.
    Schwarz, H-P.
    Reipert, B.
    EUROPEAN JOURNAL OF NEUROLOGY, 2007, 14 : 276 - 276
  • [9] Apoptosis of peripheral blood lymphocytes in patients with relapsing-remitting multiple sclerosis
    Petelin, Z
    Brinar, V
    Petravic, D
    Zurak, N
    Dubravcic, K
    Batinic, D
    MULTIPLE SCLEROSIS, 2004, 10 (7032): : S172 - S173
  • [10] Transcriptional effects of fingolimod treatment on peripheral T cells in relapsing remitting multiple sclerosis patients
    Sferruzza, Giacomo
    Clarelli, Ferdinando
    Mascia, Elisabetta
    Ferre, Laura
    Ottoboni, Linda
    Sorosina, Melissa
    Santoro, Silvia
    Filippi, Massimo
    Provero, Paolo
    Esposito, Federica
    PHARMACOGENOMICS, 2021, 23 (03) : 161 - 171
12345